Atrion Co. (NASDAQ:ATRI – Get Rating) declared a quarterly dividend on Tuesday, May 23rd, Zacks reports. Investors of record on Thursday, June 15th will be given a dividend of 2.15 per share by the medical instruments supplier on Friday, June 30th. This represents a $8.60 dividend on an annualized basis and a yield of 1.55%. The ex-dividend date is Wednesday, June 14th.
Atrion has raised its dividend by an average of 12.2% per year over the last three years and has increased its dividend annually for the last 19 consecutive years.
Atrion Stock Up 0.6 %
ATRI opened at $556.38 on Thursday. The stock has a market cap of $979.23 million, a PE ratio of 33.08 and a beta of 0.47. Atrion has a 52 week low of $534.99 and a 52 week high of $705.74. The business’s fifty day simple moving average is $610.63 and its 200 day simple moving average is $619.00.
Institutional Trading of Atrion
Large investors have recently modified their holdings of the business. FMR LLC grew its stake in shares of Atrion by 38.0% in the first quarter. FMR LLC now owns 69 shares of the medical instruments supplier’s stock worth $43,000 after purchasing an additional 19 shares during the last quarter. Citigroup Inc. grew its holdings in shares of Atrion by 63.1% during the 1st quarter. Citigroup Inc. now owns 106 shares of the medical instruments supplier’s stock worth $67,000 after acquiring an additional 41 shares during the period. Advisor Group Holdings Inc. bought a new position in shares of Atrion in the 4th quarter worth approximately $65,000. Royal Bank of Canada grew its stake in Atrion by 44.1% in the third quarter. Royal Bank of Canada now owns 134 shares of the medical instruments supplier’s stock worth $76,000 after purchasing an additional 41 shares during the period. Finally, Steward Partners Investment Advisory LLC raised its holdings in Atrion by 214.9% in the fourth quarter. Steward Partners Investment Advisory LLC now owns 148 shares of the medical instruments supplier’s stock worth $83,000 after purchasing an additional 101 shares in the last quarter. 64.90% of the stock is owned by institutional investors.
Analysts Set New Price Targets
A number of research analysts have recently issued reports on ATRI shares. StockNews.com started coverage on Atrion in a research note on Thursday, May 18th. They set a “hold” rating on the stock. TheStreet cut Atrion from a “b-” rating to a “c” rating in a research note on Monday.
Atrion Corp. engages in the manufacture and development of products for medical applications. It offers products for cardiovascular, fluid delivery, and ophthalmic. It also offers contract manufacturing and kitting services, and marine & aviation inflation components. The company was founded in 1944 and is headquartered in Allen, TX.
- Get a free copy of the StockNews.com research report on Atrion (ATRI)
- If You Can Only Pick One Stock For The Rest Of 2023, Pick Nvidia
- Upbeat Analysts Project Promising Prospects For Iridium Stock
- 2 Energy Mid-Caps Expected To Post Monster Earnings Growth
- Meet the Nasdaq’s 3 Biggest Dividend Payers
- Analog Devices Signals A Top For Semiconductor Stocks
Receive News & Ratings for Atrion Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Atrion and related companies with MarketBeat.com's FREE daily email newsletter.